Evidence map›Paper›PMID 17950772›Full record

ArticleToxicology and applied pharmacology2007

Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression.

Courtney G Woods, Oksana Kosyk, Blair U Bradford, Pamela K Ross, Amanda M Burns, Michael L Cunningham, Pingping Qu, Joseph G Ibrahim, Ivan Rusyn

Open access · greenAbstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Toxicogenomic biomarkers for liver toxicity.Journal of toxicologic pathology · 2009
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Courtney G WoodsDepartment of Environmental Sciences and Engineering, University of North Carolina, Chapel Hill, NC 27599-7431, USA.
Oksana Kosyk
Blair U Bradford
Pamela K Ross
Amanda M Burns
Michael L Cunningham
Pingping Qu
Joseph G Ibrahim
Ivan Rusyn
University of North Carolina at Chapel Hill · USNational Institute of Environmental Health Sciences · US

Funding

STOCHASTIC ANALYSIS OF FLOW AND TRANSPORT PHENOMENAP42ES005948 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FRY, REBECCA · 1992 to 2017
$45.4M
Profiles of Sucsceptibility to Toxicant StressU19ES011391 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAUFMANN, WILLIAM K · 2001 to 2007
$8.4M
Bioengineering partnership to improve chemical hazard testing paradigmsR01ES015241 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUSYN, IVAN · 2008 to 2012
$3.1M
Molecular Mechanisms of Phthalate-induced CarcinogenesisR01ES012686 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUSYN, IVAN · 2004 to 2007
$1.1M
MINORITY PREDOCTORAL FELLOWSHIP PROGRAMF31ES013342 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WOODS, COURTNEY G · 2004 to 2006
$94k
NIEHS NIH HHS F31 ES013342NIEHS NIH HHS P42 ES005948NIEHS NIH HHS R01 ES012686NIEHS NIH HHS R01 ES015241NIEHS NIH HHS U19 ES011391
6 · The paper itself

Abstract

Administration of peroxisome proliferators to rodents causes proliferation of peroxisomes, induction of beta-oxidation enzymes, hepatocellular hypertrophy and hyperplasia, with chronic exposure ultimately leading to hepatocellular carcinomas. Many responses associated with peroxisome proliferators are nuclear receptor-mediated events involving peroxisome proliferators-activated receptor alpha (PPARalpha). A role for nuclear receptor-independent events has also been shown, with evidence of Kupffer cell-mediated free radical production, presumably through NAPDH oxidase, induction of redox-sensitive transcription factors involved in cytokine production and cytokine-mediated cell replication following acute treatment with peroxisome proliferators in rodents. Recent studies have demonstrated, by using p47(phox)-null mice which are deficient in NADPH oxidase, that this enzyme is not related to the phenotypic events caused by prolonged administration of peroxisome proliferators. In an effort to determine the timing of the transition from Kupffer cell-to PPARalpha-dependent modulation of peroxisome proliferator effects, gene expression was assessed in liver from Pparalpha-null, p47(phox)-null and corresponding wild-type mice following treatment with 4-chloro-6-(2,3-xylidino)-pyrimidynylthioacetic acid (WY-14,643) for 8 h, 24 h, 72 h, 1 week or 4 weeks. WY-14,643-induced gene expression in p47(phox)-null mouse liver differed substantially from wild-type mice at acute doses and striking differences in baseline expression of immune related genes were evident. Pathway mapping of genes that respond to WY-14,643 in a time- and dose-dependent manner demonstrates suppression of immune response, cell death and signal transduction and promotion of lipid metabolism, cell cycle and DNA repair. Furthermore, these pathways were largely dependent on PPARalpha, not NADPH oxidase demonstrating a temporal shift in response to peroxisome proliferators. Overall, this study shows that NADPH oxidase-dependent events, while detectable following acute treatment, are transient. To the contrary, a strong PPARalpha-specific gene signature was evident in mice that were continually exposed to WY-14,643.

Indexed as

AnimalsGene Expression ProfilingGene Expression RegulationKupffer CellsLiverMaleMiceMice, KnockoutNADPH OxidasesOligonucleotide Array Sequence AnalysisPeroxisome ProliferatorsPPAR alphaPyrimidinesTime FactorsNADPH OxidasesPeroxisome Proliferatorspirinixic acidPPAR alphaPyrimidines

Identifiers

PMID17950772
PMCPMC2153436
OpenAlexW2134182089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.